Hydrogel-Enhanced Autologous Chondrocyte Implantation for Cartilage Regeneration—An Update on Preclinical Studies
Bioengineering · 19.11.2024 · 11 (11) · 1164
DOI: 10.3390/bioengineering11111164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 19.11.2024. Verfasst von Xenab Ahmadpoor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Orthopaedic Surgery at the University of Pittsburgh.
Abstract (Originalsprache)
Autologous chondrocyte implantation (ACI) and matrix-induced ACI (MACI) have demonstrated improved clinical outcomes and reduced revision rates for treating osteochondral and chondral defects. However, their ability to achieve lasting, fully functional repair remains limited. To overcome these challenges, scaffold-enhanced ACI, particularly utilizing hydrogel-based biomaterials, has emerged as an innovative strategy. These biomaterials are intended to mimic the biological composition, structural organization, and biomechanical properties of native articular cartilage. This review aims to provide comprehensive and up-to-date information on advancements in hydrogel-enhanced ACI from the past decade. We begin with a brief introduction to cartilage biology, mechanisms of cartilage injury, and the evolution of surgical techniques, particularly looking at ACI. Subsequently, we review the diversity of hydrogel scaffolds currently undergoing development and evaluation in preclinical studies for articular cartilage regeneration, emphasizing chondrocyte-laden hydrogels applicable to ACI. Finally, we address the key challenges impeding effective clinical translation, with particular attention to issues surrounding fixation and integration, aiming to inform and guide the future progression of tissue engineering strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
- Department of Molecular Oncology, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
- Department of Sports Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518025, China.
- Clinical College of the Second Shenzhen Hospital, Anhui Medical University, Shenzhen 518025, China.
- Department of Bioengineering, University of Pittsburgh Swanson School of Engineering, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
- Orland Bethel Family Musculoskeletal Research Center, University of Pittsburgh, Pittsburgh, PA 15260, USA.
ORCID-Profile: Xenab Ahmadpoor, Nerone Douglas
Förderung
- Department of Orthopaedic Surgery at the University of Pittsburgh
Zitieren
APA
Ahmadpoor, X., Sun, J., Douglas, N., Zhu, W., & Lin, H. (2024). Hydrogel-Enhanced Autologous Chondrocyte Implantation for Cartilage Regeneration—An Update on Preclinical Studies. Bioengineering, 11(11), 1164. https://doi.org/10.3390/bioengineering11111164
Vancouver
Ahmadpoor X, Sun J, Douglas N, Zhu W, Lin H. Hydrogel-Enhanced Autologous Chondrocyte Implantation for Cartilage Regeneration—An Update on Preclinical Studies. Bioengineering. 2024;11(11):1164. doi:10.3390/bioengineering11111164
BibTeX
@article{Ahmadpoor2024,
author = {Ahmadpoor, Xenab and Sun, Jessie and Douglas, Nerone and Zhu, Weimin and Lin, Hang},
title = {Hydrogel-Enhanced Autologous Chondrocyte Implantation for Cartilage Regeneration—An Update on Preclinical Studies},
journal = {Bioengineering},
year = {2024},
volume = {11},
number = {11},
pages = {1164},
doi = {10.3390/bioengineering11111164}
}
EUVIMED